As the above studies were all performed on the PAAD cohort of TCGA, we here employed two validation cohorts, GSE57495 and GSE78229, to validate the prognostic value of BMP4 and thus exclude the possibility that the effect of BMP4 on PAAD was only restricted to TCGA cohort. The gene discussed is BMP4; the disease is pancreatic adenocarcinoma.